Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 28, 2025
Mitolyn WARNING (MUST-READ): Medical Investigator Exposes The Facts About Mitochondrial Health & Weight Loss
GlobeNewswire
·
March 28, 2025
Vancouver, March 28, 2025 (GLOBE NEWSWIRE) -- Mitolyn In a world where weight loss solutions come and go, Mitolyn has emerged as a frontrunner, capturing the attention of thousands looking for a sustainable, science-backed approach to shedding excess fat. …
HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results
GlobeNewswire
·
March 28, 2025
MIRAMAR, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …
Sumatra Tonic: Introducing Sumatra Tonic as the Weird Blue Tonic for Weight Loss Support
GlobeNewswire
·
March 28, 2025
TALLMADGE, Ohio, March 28, 2025 (GLOBE NEWSWIRE) -- Sumatra Tonic emerges as a science-backed breakthrough in a market brimming with superficial solutions and quick fixes, offering targeted support for deep sleep disruption, blue light overload, and …
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference
GlobeNewswire
·
March 28, 2025
PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities …
Excitement Builds for Tremfya Among US Gastroenterologists as the FDA Approves its Expansion into Crohn’s Disease, Suggesting the Brand May Impact Competitor Skyrizi’s Growth
GlobeNewswire
·
March 28, 2025
EXTON, PA, March 28, 2025 (GLOBE NEWSWIRE) -- The treatment landscape for Crohn’s disease continues to evolve with the recent FDA approval of Johnson and Johnson Innovative Medicine’s Tremfya (guselkumab). This significant milestone makes Tremfya the …
Gluco Extend Reviews (Is It Safe And Legit?) Investigative Report On Ingredients, Benefits, And Side Effects!
GlobeNewswire
·
March 28, 2025
BOISE, Idaho, March 28, 2025 (GLOBE NEWSWIRE) -- A healthy person cannot be simply determined as someone with a great body or clear skin. For a person to be really considered healthy, they should have healthy bodily functions like healthy blood sugar …
Strategic update on the progress and development of Molecure's key clinical projects in 2024
GlobeNewswire
·
March 28, 2025
Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A summary of the most important events of 2024: Initiation …
Norton Orthopedic Institute surgeon performs new robotic-assisted shoulder replacement
GlobeNewswire
·
March 28, 2025
LOUISVILLE, Ky., March 28, 2025 (GLOBE NEWSWIRE) -- New robotic technology has arrived at Norton Brownsboro Hospital. Justin M. Givens, M.D., orthopedic surgeon with Norton Orthopedic Institute, is among the first five surgeons in the country — and the …
Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
GlobeNewswire
·
March 28, 2025
SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it has …
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
GlobeNewswire
·
March 28, 2025
WALTHAM, Mass., March 28, 2025 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a commercial-stage immunotherapy and targeted oncology company, today announced financial results for the fiscal year ended December 31, 2024, …
Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data
GlobeNewswire
·
March 28, 2025
Grand Cayman, Cayman Islands, March 28, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …
Medical Humidifier Market worth US$1,211.7 million by 2029 with 5.6% CAGR | MarketsandMarkets™.
GlobeNewswire
·
March 28, 2025
Delray Beach, FL, March 28, 2025 (GLOBE NEWSWIRE) -- The global Medical Humidifier Market, valued at US$878.4 million in 2023, is forecasted to grow at a robust CAGR of 5.6%, reaching US$922.8 million in 2024 and an impressive US$1,211.7 million by 2029. …
SS Innovations Continues its International Growth, Receiving Medical Device Regulatory Approvals for the SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine
GlobeNewswire
·
March 28, 2025
FORT LAUDERDALE, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable …
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
GlobeNewswire
·
March 28, 2025
LITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary …
Gain Therapeutics Announces Poster Presentation at AD/PD 2025
GlobeNewswire
·
March 28, 2025
BETHESDA, Md., March 28, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show
GlobeNewswire
·
March 28, 2025
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its participation as a gold …
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
GlobeNewswire
·
March 28, 2025
PROVIDENCE, R.I., March 28, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company dedicated to advancing innovative treatments for cancer, infectious diseases, and fibrosis, today announced that the China National …
Tr1X Announces Succession Plan: Appoints David de Vries CEO, Effective June 1; Bill Lis to Serve as Executive Chairman
GlobeNewswire
·
March 28, 2025
SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory …
Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity
GlobeNewswire
·
March 28, 2025
CB1 inverse agonism is a clinically validated mechanism to induce weight loss CRB-913 is markedly more peripherally restricted compared to monlunabant and rimonabant SAD/MAD Phase 1 trial scheduled for completion Q3 2025 and Phase 1b dose-range finding …
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure
GlobeNewswire
·
March 28, 2025
Marlton, NJ, March 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it received European CE Mark approval for an expanded …